Pfizer and Drexel develop Minecraft-like game to help young hemophiliacs and caregivers
Patient engagement and education seem to be the largest drivers for building games for healthcare organizations.
What are some of Geisinger’s priorities with Regeneron collaboration?
Geisinger Health System announced this week that it’s working with Regeneron Pharmaceuticals (NASDAQ: REGN) in a project to use genetic samples from more than 100,000 volunteers to identify and validate associations between genes and human disease. The move reflects Geisinger’s efforts to advance genomic analysis from the research stage to the point where it is […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
FDA approval for drug for Peyronie’s disease adds alternative to surgery
The U.S. Food and Drug Administration’s approval of Auxilium Pharmaceuticals’ drug Xiaflex (NASDAQ: AUXL) makes it the first medication to treat Peyronie’s disease. It is a painful condition affecting the penis and the drug could lead to more people seeking treatment. Peyronie’s disease is a connective tissue disorder that results in the growth of fibrous plaque […]
Biotech startup nets $3.4M to advance treatments for MRSA, salmonella bacterial infections
MRSA is responsible for about 19,000 deaths and 368,000 hospitalizations in the U.S. each year, with annual costs of up to $4.2 billion to treat it, according to Pew Health Initiatives. The staph infection is resistant to most commonly used antibiotics. It’s just one of the hospital-acquired infections that hospitals are combating. A life science […]
To advance treatment for post traumatic stress disorder, biotechnology firm raises $2.2M
Mood and behavior disorders, such as post traumatic stress and depression, affect up to 40 million in the U.S. A biotechnology company developing a way to treat the disorders has raised $2.2 million, according to a Form D filing with the U.S. Securities and Exchange Commission. The financing will help Azevan Pharmaceuticals advance its two […]
NuPathe gets FDA approval for migraine patch
Migraine sufferers (and no doubt some investors) will be feeling some relief tonight after NuPathe (NASDAQ: PATH) secured approval from the U.S. Food and Drug Administration for its lead product — the first skin patch to deliver sumatriptan, a widely used migraine medication. The delivery system is aimed at people who get migraines and experience […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Science Center CEO Stephen Tang: Startups are necessary but not enough
Stephen Tang, the CEO of the University City Science Center, says the center gives Philadelphia a unique strength: neutral ground for startups and larger companies and institutions to exchange ideas and collaborate. This kind of meeting place can do everything from provide greater interaction between groups within the life sciences community to provide a forum […]